Company: RPTX
Filing Date: 2025-06-02
Form Type: 8-K/A
Source: 0001193125-25-133312
Chunk: 2

Company: Repare Therapeutics Inc.
Filing Date: 2025-06-02
Form: 8-K/A
Chunk 2
---
 cash severance equal to the sum of her base salary and the higher of her target bonus for the year in which the termination occurs or the annual bonus received for the prior year; (2) continued participation in the Company’s group insurance plans and employee benefits for up to 12 months; and (3) full accelerated vesting of her option awards and restricted stock units that are subject to a time-based vesting schedule, and Ms. Alves’ vested option shall remain exercisable for up to nine months following such termination.

The summary of the Employment Agreement set forth above does not purport to be a complete statement of the terms of such document, and is qualified in its entirety by reference to the full text of the Employment Agreement, a copy of which will be filed with the Company’s Quarterly Report on Form 10-Q for the quarter ending June 30, 2025, and upon filing will be incorporated herein by reference.

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.**

| REPARE THERAPEUTICS INC. |     |                                                                           |
| By:                      |     | /s/ Steve Forte                                                           |
|                          |     | Steve FortePresident, Chief Executive Officer and Chief Financial Officer |

Dated: June 2, 2025